This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval for the pure vision (balafilcon a) visibility tinted contact lens. The device is indicated for daily wear or extended wear from 1 to 30 days between removals, for cleaning and disinfection or disposal of the lens, as recommended by the eye care professional. The lens is indicated for the correction of refractive ametropia (myopia and hyperopia) in aphakic and/or not-aphakic persons with non-diseased eyes, exhibiting astigmatism of 2. 00 diopters or less, that does not interfere with visual acuity. The lens may be prescribed for frequent/planned replacement wear or disposable wear in spherical powers ranging from +8. 00d to -20. 00d when prescribed for up to 30 days of extended wear and from +20. 00d to -20. 00d for daily wear or extended wear up to 7 days.
Device | PUREVISION(TM)(BALAFILCON A) VISIBILITY TINTED CONTACT LENSES |
Classification Name | Lenses, Soft Contact, Extended Wear |
Generic Name | Lenses, Soft Contact, Extended Wear |
Applicant | Bausch & Lomb, Inc. |
Date Received | 2001-05-30 |
Decision Date | 2001-11-20 |
Notice Date | 2001-11-29 |
PMA | P980006 |
Supplement | S004 |
Product Code | LPM |
Docket Number | 01M-0531 |
Advisory Committee | Ophthalmic |
Supplement Type | Panel Track |
Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
Expedited Review | No |
Combination Product | No |
Applicant Address | Bausch & Lomb, Inc. 1400 North Goodman St. rochester, NY 14609-3547 |
Summary: | Summary of Safety and Effectiveness |
Labeling: | Labeling Labeling Part 2 |
Post-Approval Study: | Show Report Schedule and Study Progress |
Approval Order: | Approval Order |
Supplement Number | Date | Supplement Type |
---|---|---|
P980006 | Original Filing | |
S035 | 2022-08-12 | 30-day Notice |
S034 | 2022-02-22 | 30-day Notice |
S033 | 2021-12-15 | 30-day Notice |
S032 | 2021-06-03 | Real-time Process |
S031 | ||
S030 | 2020-09-02 | 30-day Notice |
S029 | 2019-07-15 | Real-time Process |
S028 | ||
S027 | 2018-03-12 | 30-day Notice |
S026 | 2017-12-26 | 30-day Notice |
S025 | 2015-11-20 | 30-day Notice |
S024 | 2015-02-20 | 30-day Notice |
S023 | 2014-09-15 | 30-day Notice |
S022 | 2014-04-14 | Normal 180 Day Track No User Fee |
S021 | 2013-06-24 | 30-day Notice |
S020 | 2011-06-08 | 30-day Notice |
S019 | 2011-05-19 | 30-day Notice |
S018 | 2010-12-03 | Normal 180 Day Track No User Fee |
S017 | 2010-12-01 | 30-day Notice |
S016 | 2010-12-01 | 30-day Notice |
S015 | 2010-07-22 | Normal 180 Day Track |
S014 | 2008-11-12 | Real-time Process |
S013 | 2008-09-24 | Real-time Process |
S012 | 2008-04-02 | Real-time Process |
S011 | 2007-08-20 | 30-day Notice |
S010 | 2006-08-24 | 30-day Notice |
S009 | ||
S008 | 2005-04-25 | Real-time Process |
S007 | 2005-03-03 | Normal 180 Day Track |
S006 | 2005-02-03 | Real-time Process |
S005 | 2004-01-06 | Normal 180 Day Track No User Fee |
S004 | 2001-05-30 | Panel Track |
S003 | 2001-01-09 | Normal 180 Day Track |
S002 | 1999-09-01 | Normal 180 Day Track |
S001 | 1999-06-29 | Normal 180 Day Track |